Cargando…

Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms

In the local treatment of the esophageal mucosa, the retention time of the different dosage forms, such as tablets, films or liquids, is of high relevance for the effective treatment of diseases. Unfortunately, there are only few in vitro models describing the esophageal route of administration. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Brokmann, Friederike, Feindt, Franziska, Weitschies, Werner, Rosenbaum, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459172/
https://www.ncbi.nlm.nih.gov/pubmed/37631487
http://dx.doi.org/10.3390/polym15163430
_version_ 1785097346018705408
author Brokmann, Friederike
Feindt, Franziska
Weitschies, Werner
Rosenbaum, Christoph
author_facet Brokmann, Friederike
Feindt, Franziska
Weitschies, Werner
Rosenbaum, Christoph
author_sort Brokmann, Friederike
collection PubMed
description In the local treatment of the esophageal mucosa, the retention time of the different dosage forms, such as tablets, films or liquids, is of high relevance for the effective treatment of diseases. Unfortunately, there are only few in vitro models describing the esophageal route of administration. To predict the behaviour of an esophageal-applied dosage form, it is necessary to simulate the site of application in a biorelevant way. The aim of this work was to develop two test setups for an esophageal peristalsis model which was described in a previous study. Different parameters such as flow rate, peristalsis, angle of inclination or mucous membrane were varied or introduced into the model. A stimulated and unstimulated modus were developed and tested with two different dosage forms. The time until the dosage form was cleared from the in vitro model was shorter with the stimulated than with the unstimulated modus. Also, esophageal-applied films had a prolonged transit time compared to a viscous syrup. The modification of the simulated esophageal surface made it possible to estimate the retention time of the dosage forms. It could be demonstrated that the residence time of a dosage form depends on different parameters affecting each other.
format Online
Article
Text
id pubmed-10459172
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104591722023-08-27 Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms Brokmann, Friederike Feindt, Franziska Weitschies, Werner Rosenbaum, Christoph Polymers (Basel) Article In the local treatment of the esophageal mucosa, the retention time of the different dosage forms, such as tablets, films or liquids, is of high relevance for the effective treatment of diseases. Unfortunately, there are only few in vitro models describing the esophageal route of administration. To predict the behaviour of an esophageal-applied dosage form, it is necessary to simulate the site of application in a biorelevant way. The aim of this work was to develop two test setups for an esophageal peristalsis model which was described in a previous study. Different parameters such as flow rate, peristalsis, angle of inclination or mucous membrane were varied or introduced into the model. A stimulated and unstimulated modus were developed and tested with two different dosage forms. The time until the dosage form was cleared from the in vitro model was shorter with the stimulated than with the unstimulated modus. Also, esophageal-applied films had a prolonged transit time compared to a viscous syrup. The modification of the simulated esophageal surface made it possible to estimate the retention time of the dosage forms. It could be demonstrated that the residence time of a dosage form depends on different parameters affecting each other. MDPI 2023-08-17 /pmc/articles/PMC10459172/ /pubmed/37631487 http://dx.doi.org/10.3390/polym15163430 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Brokmann, Friederike
Feindt, Franziska
Weitschies, Werner
Rosenbaum, Christoph
Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms
title Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms
title_full Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms
title_fullStr Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms
title_full_unstemmed Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms
title_short Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms
title_sort development of test programs for the biorelevant characterization of esophageal-applied dosage forms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459172/
https://www.ncbi.nlm.nih.gov/pubmed/37631487
http://dx.doi.org/10.3390/polym15163430
work_keys_str_mv AT brokmannfriederike developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms
AT feindtfranziska developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms
AT weitschieswerner developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms
AT rosenbaumchristoph developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms